Daianne N.M. Torres, M.Sc.

UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil 
"Daianne Torres"
Mean distance: 17.48 (cluster 58)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rebbeck TR, Friebel TM, Friedman E, et al. (2018) Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation
Michailidou K, Lindström S, Dennis J, et al. (2017) Association analysis identifies 65 new breast cancer risk loci. Nature
Milne RL, Kuchenbaecker KB, Michailidou K, et al. (2017) Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics
Liu J, Lončar I, Collée JM, et al. (2016) rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports. 6: 36874
Lawrenson K, Kar S, McCue K, et al. (2016) Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675
Southey MC, Goldgar DE, Winqvist R, et al. (2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics
Pelttari LM, Khan S, Vuorela M, et al. (2016) RAD51B in Familial Breast Cancer. Plos One. 11: e0153788
Zhao Z, Wen W, Michailidou K, et al. (2016) Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control : Ccc
Dunning AM, Michailidou K, Kuchenbaecker KB, et al. (2016) Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics
Meeks HD, Song H, Michailidou K, et al. (2016) BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108
See more...